ACC 2018

2018-03-10 - 2018-03-12
Orlando, United States

ESC 2017

2017-08-26 - 2017-08-30
Barcelona, Spain

ACC 2017

2017-03-17 - 2017-03-19
Washington DC, United States

AHA 2016

2016-11-13 - 2016-11-16
New Orleans, United States

ESC Rome 2016

2016-08-27 - 2016-08-31
Rome, Italy

AHA 2015

2015-11-07 - 2015-11-11
Orlando, United States

ESC 2015

2015-08-29 - 2015-09-02
London, United Kingdom

CE Summit 2014

2014-12-06 - 2014-12-07
Ljubljana, Slovenia

AHA 2014

2014-11-15 - 2014-11-19
Chicago, United States
Search in Scientific Content:
Date
Filters:
The Risk o
5:25

The Risk of Early Recurrent MI: What is the Role of Cholesterol Efflux and ApoA-I?

Presenter: Eliot A. Brinton
ACC 2023
Bempedoic
5:48

Bempedoic Acid Improves Cardiovascular Outcomes In Statin Intolerant Patients At High Cardiovascular Risk

Presenter: Eliot A. Brinton
ACC 2023
How to inc
6:19

How to increase prescription of evidence-based therapies in adults with T2D and ASCVD? - The COORDINATE-Diabetes Study

Presenter: Neha Pagidipati
ACC 2023
The FREEDO
6:42

The FREEDOM COVID Anticoagulation Strategy Randomized Trial

Presenter: Gregg Stone
ACC 2023
Minimally
7:09

Minimally Invasive Versus Conventional Sternotomy For Mitral Valve Repair Surgery - UK Mini Mitral Trial

Presenter: Enoch Akowuah
ACC 2023
Can Patien
3:56

Can Patients with Hypertrophic Cardiomyopathy do Vigorous Exercise? - A Multinational Lifestyle And Exercise Study

Presenter: Rachel Lampert
ACC 2023
Efficacy a
3:31

Efficacy and Safety of Oral PCSK9 Inhibitor, MK-0616 in the Treatment of Hypercholesterolemia

Presenter: Eliot A. Brinton
ACC 2023
Transcathe
4:33

Transcatheter Edge-to-Edge Repair of Functional Mitral Regurgitation in Heart Failure - The COAPT Trial

Presenter: Gregg Stone
ACC 2023
Elevated L
16:07

Elevated Lipoprotein(a) as a Risk Enhancing Factor for Atherosclerotic Cardiovascular Disease

Presenter: Nathan D. Wong
ACC 2023
Sotatercep...
8:26

Sotatercept in combination with background therapy for the treatment of Pulmonary Arterial Hypertension — STELLAR Trial

Presenter: Marius Hoeper
ACC 2023
The Omega-
6:27

The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA

Presenter: Eliot A. Brinton
ACC 2023
A fresh lo
11:34

A fresh look at pulmonary hypertension: practical takeaways for patient management

Presenter: John Gerard Coghlan
ESC 2022
Facing ant
11:52

Facing anticoagulation dilemmas in venous thromboembolism

Presenter: Ingrid Pabinger
ESC 2022
Influenza
5:14

Influenza Vaccine Among Patients with Acute Coronary Syndromes: the VIP-ACS trial

Presenter: Remo H. M. Furtado
ESC 2022
The import
6:20

The importance of optimal RAASi therapy in heart failure

Presenter: Dan Atar
ESC 2022
Chronic co
8:45

Chronic coronary syndrome: re-thinking treatment management and outcome priorities

Presenter: Athanasios John Manolis
ESC 2022
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients

Presenter: Andreas Goette
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
HOPE 4 - I
5:19

HOPE 4 - Impact on cardiovascular risk of a community based multifaceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study

Presenter: J.D. Schwalm
SYNTAXES:
7:28

SYNTAXES: Ten-Year Survival after Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention: The SYNTAX Extended Survival study

Presenter: Daniel Johannes Franciscus Maria Thuijs
MITRA-FR -
8:46

MITRA-FR - 2 years follow-Up of the MITRA-FR study a randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation

Presenter: Jean-Francois Obadia
DAPA HF Th
6:20

DAPA HF The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure Trial

Presenter: John McMurray
CONDI-2/ER
4:010

CONDI-2/ERIC-PPCI Effect of remote ischemic conditioning on clinical outcomes in patients with Stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Presenter: Hans Erik Botker
The Omega-
1:17

The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA

Presenter: Eliot A. Brinton
Elevated L
1:18

Elevated Lipoprotein(a) as a Risk Enhancing Factor for Atherosclerotic Cardiovascular Disease

Presenter: Nathan D. Wong
Treatment
3:27

Treatment of iron deficiency in acute and chronic heart failure

Presenter: Piotr Ponikowski
Alcohol se
6:32

Alcohol septal ablation in hypertrophic cardiomyopathy: past and future

Presenter: Hubert Seggewiss
The use of
3:35

The use of SGLT2 inhibitors in the prevention and treatment of heart failure

Presenter: Petar M. Seferovic
Direct myo
5:15

Direct myosin inhibitors in hypertrophic cardiomyopathy: a new era?

Presenter: Iacopo Olivotto
Liraglutid
13:26

Liraglutide for Weight Management in the Real World

Presenter: Roman Vangoitsenhoven
The role o
10:22

The role of GLP-1 receptor agonists in weight reduction and cardiovascular risk reduction

Presenter: Michael A. Nauck
Clinical I
8:59

Clinical Impact of Liraglutide as a Treatment of Obesity

Presenter: Alexander Miras